Literature DB >> 21565550

Immune escape of the human facultative pathogenic yeast Candida albicans: the many faces of the Candida Pra1 protein.

Peter F Zipfel1, Christine Skerka, Danny Kupka, Shanshan Luo.   

Abstract

Infectious diseases caused by human pathogenic fungi represent a major and global health problem. Based on the limited efficacy of existing drugs and the increasing resistance to antifungal compounds, new strategies are urgently needed to fight such fungal infections. The medically important pathogen Candida albicans can exist as an opportunistic yeast, but can also cause severe diseases, septicaemia, and death. In order to establish new strategies to fight Candida infections and to interfere with survival of the pathogen, it is highly relevant to understand the molecular and immunology interactions between the pathogen C. albicans and the human host. This immune cross talk has moved into the focus of infectious disease research. In this review, we summarize the diverse and multiple levels of the immune cross talk between the fungal pathogen C. albicans and the human host. In particular, we define how one single fungal protein Pra1 (pH-regulated antigen 1) interferes and controls host immune attack at multiple levels and thus contributes to fungal immune escape. Candida Pra1 represents a promising candidate for immune interference.
Copyright © 2011 Elsevier GmbH. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21565550     DOI: 10.1016/j.ijmm.2011.04.010

Source DB:  PubMed          Journal:  Int J Med Microbiol        ISSN: 1438-4221            Impact factor:   3.473


  30 in total

1.  Candida albicans specializations for iron homeostasis: from commensalism to virulence.

Authors:  Suzanne M Noble
Journal:  Curr Opin Microbiol       Date:  2013-10-10       Impact factor: 7.934

2.  Signaling domains of mucin Msb2 in Candida albicans.

Authors:  Marc Swidergall; Lasse van Wijlick; Joachim F Ernst
Journal:  Eukaryot Cell       Date:  2015-01-30

Review 3.  Interaction of Candida albicans with host cells: virulence factors, host defense, escape strategies, and the microbiota.

Authors:  Sarah Höfs; Selene Mogavero; Bernhard Hube
Journal:  J Microbiol       Date:  2016-02-27       Impact factor: 3.422

Review 4.  An evolutionary perspective on zinc uptake by human fungal pathogens.

Authors:  Duncan Wilson
Journal:  Metallomics       Date:  2015-06       Impact factor: 4.526

5.  Collectin-11/MASP complex formation triggers activation of the lectin complement pathway--the fifth lectin pathway initiation complex.

Authors:  Ying Jie Ma; Mikkel-Ole Skjoedt; Peter Garred
Journal:  J Innate Immun       Date:  2012-12-04       Impact factor: 7.349

6.  Design, characterization, and in vitro evaluation of antifungal polymeric films.

Authors:  Daniel A Real; María V Martinez; Agustín Frattini; Marina Soazo; Alicia G Luque; Marisa S Biasoli; Claudio J Salomon; Alejandro C Olivieri; Darío Leonardi
Journal:  AAPS PharmSciTech       Date:  2012-12-08       Impact factor: 3.246

Review 7.  Innate immune cell response upon Candida albicans infection.

Authors:  Yulin Qin; Lulu Zhang; Zheng Xu; Jinyu Zhang; Yuan-Ying Jiang; Yongbing Cao; Tianhua Yan
Journal:  Virulence       Date:  2016-04-14       Impact factor: 5.882

8.  Candida albicans scavenges host zinc via Pra1 during endothelial invasion.

Authors:  Francesco Citiulo; Ilse D Jacobsen; Pedro Miramón; Lydia Schild; Sascha Brunke; Peter Zipfel; Matthias Brock; Bernhard Hube; Duncan Wilson
Journal:  PLoS Pathog       Date:  2012-06-28       Impact factor: 6.823

9.  Transcriptome Analysis of the Japanese Pine Sawyer Beetle, Monochamus alternatus, Infected with the Entomopathogenic Fungus Metarhizium anisopliae JEF-197.

Authors:  Jong-Cheol Kim; Mi-Rong Lee; Sihyeon Kim; So-Eun Park; Se-Jin Lee; Tae-Young Shin; Woo-Jin Kim; Jaesu Kim
Journal:  J Fungi (Basel)       Date:  2021-05-10

10.  Zinc exploitation by pathogenic fungi.

Authors:  Duncan Wilson; Francesco Citiulo; Bernhard Hube
Journal:  PLoS Pathog       Date:  2012-12-20       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.